Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVE: Levosimendan in Noncardiac Surgery
NCT04329624Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2020
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levosimendan in Myocardial injury, myocardial infarction (MI), sponsored by Medical University of Vienna. Started Oct 2020; status: completed.
02
Drugs
levosimendan
03
Conditions
Myocardial injurymyocardial infarction (MI)
Beyond the preview
Go deeper on NCT04329624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04329624.